文献检索
文档翻译
深度研究
Zotero 插件
邀请有礼
套餐&价格
历史记录
Suppr
超能文献
应用&插件
Note for guidance. Guidelines for medicinal products derived from human blood and plasma. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
出版信息
Biologicals. 1992 Jun;20(2):159-64.
PMID:
1389112
Abstract
摘要
相似文献
1
Note for guidance. Guidelines for medicinal products derived from human blood and plasma. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
指导说明。人血和血浆衍生药品指南。专利药品委员会:生物技术/药学特设工作组和药品安全工作组。
Biologicals. 1992 Jun;20(2):159-64.
2
Note for guidance. Guidelines for minimizing the risk of transmitting agents causing spongiform encephalopathy via medicinal products. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
指导说明。关于将导致海绵状脑病的病原体通过药品传播的风险降至最低的指南。专利药品委员会:生物技术/药学特设工作组和药品安全工作组。
Biologicals. 1992 Jun;20(2):155-8.
3
EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
欧洲经济共同体监管文件。指导说明。病毒去除和灭活程序的验证。专利药品委员会:生物技术/药学特设工作组和药品安全工作组。
Biologicals. 1991 Jul;19(3):247-51.
4
Note for guidance. Production and quality control of cytokine products derived by biotechnological processes. Committee for Proprietary Medicinal Products: Ad hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
指导说明。生物技术工艺生产的细胞因子产品的生产与质量控制。专利药品委员会:生物技术/药学特设工作组及药品安全工作组。
Biologicals. 1991 Apr;19(2):125-31.
5
Note for guidance. Production and quality control of human monoclonal antibodies. Committee for Proprietary Medicinal Products: Ad hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
指导说明。人源单克隆抗体的生产与质量控制。专利药品委员会:生物技术/药学特设工作组及药品安全工作组。
Biologicals. 1991 Apr;19(2):133-8.
6
European project concerning the guidelines on medicinal products derived from human blood and plasma.
欧洲关于人血和血浆衍生药品指南的项目。
Dev Biol Stand. 1991;75:237-40.
7
European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products.
欧洲关于重组蛋白、单克隆抗体和血浆衍生药品病毒安全性的监管指南。
Dev Biol (Basel). 2004;118:3-10.
8
Notes to applicants for marketing authorizations on the pre-clinical biological safety testing of medicinal products derived from biotechnology (and comparable products derived from chemical synthesis). Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety of Medicines.
J Biol Stand. 1989 Jul;17(3):203-12. doi: 10.1016/0092-1157(89)90012-7.
9
Notes to applicants for marketing authorizations on the production and quality control of medicinal products derived by recombinant DNA technology. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy.
J Biol Stand. 1989 Jul;17(3):223-31. doi: 10.1016/0092-1157(89)90014-0.
10
New trends in plasma fractionation.
Haematologia (Budap). 1983;16(1-4):39-51.
引用本文的文献
1
Virus contaminations of cell cultures - A biotechnological view.
病毒污染细胞培养物——生物技术视角。
Cytotechnology. 2002 Jul;39(2):91-116. doi: 10.1023/A:1022969101804.
文献AI研究员
20分钟写一篇综述,助力文献阅读效率提升50倍。
立即体验
用中文搜PubMed
大模型驱动的PubMed中文搜索引擎
马上搜索
文档翻译
学术文献翻译模型,支持多种主流文档格式。
立即体验
应用&插件
Zotero 插件
浏览器插件
Mac 客户端
Windows 客户端
微信小程序
定价
高级版会员
购买积分包
购买API积分包
服务
文献检索
文档翻译
深度研究
API 文档
MCP 服务
关于我们
关于 Suppr
公司介绍
联系我们
用户协议
隐私条款
关注我们
Suppr 超能文献
核心技术专利:
CN118964589B
侵权必究
粤ICP备2023148730 号-1
Suppr @ 2026